Early Use of Allograft Skin : Are 3-Day Microbiologic Cultures Safe?BRITTON-BYRD, Benita W; LYNCH, James P; WILLIAMSON, Stephen et al.The Journal of trauma, injury, infection, and critical care. 2008, Vol 64, Num 3, pp 816-818, issn 1079-6061, 3 p.Article

A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck : Southwest oncology group study 0007WORDEN, Francis P; MOON, James; SAMLOWSKI, Wolfram et al.Cancer. 2006, Vol 107, Num 2, pp 319-327, issn 0008-543X, 9 p.Article

Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): A Southwest oncology group studyLE, Quynh-Thu; MCCOY, Jason; WILLIAMSON, Stephen et al.Clinical cancer research. 2004, Vol 10, Num 16, pp 5418-5424, issn 1078-0432, 7 p.Article

Bevacizumab and Erlotinib in Previously Untreated Inoperable and Metastatic Hepatocellular CarcinomaGOVINDARAJAN, Rangaswamy; SIEGEL, Eric; MAKHOUL, Issam et al.American journal of clinical oncology. 2013, Vol 36, Num 3, pp 254-257, issn 0277-3732, 4 p.Article

Phase II trial of pyrazoloacridine in advanced non-small cell carcinoma of the lungBASTASCH, Michael; PANELLA, Timothy J; KRETZSCHMER, Shari L et al.Investigational new drugs. 2002, Vol 20, Num 3, pp 339-342, issn 0167-6997Article

Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF geneKUSUMOTO, Masahiro; UMEDA, Shuyo; IKUBO, Akashi et al.Cancer immunology and immunotherapy. 2001, Vol 50, Num 7, pp 373-381, issn 0340-7004Article

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non-Small-Cell Lung Cancer : Results From Southwest Oncology Group Randomized TrialsLARA, Primo N; REDMAN, Mary W; KELLY, Karen et al.Journal of clinical oncology. 2008, Vol 26, Num 3, pp 463-467, issn 0732-183X, 5 p.Article

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420WILLIAMSON, Stephen K; MOON, James; HUANG, Chao H et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3330-3335, issn 0732-183X, 6 p.Article

Preclinical antitumor activity of a nanoparticulate SN38AL-KASSPOOLES, Mazin F; WILLIAMSON, Stephen K; HENRY, David et al.Investigational new drugs. 2013, Vol 31, Num 4, pp 871-880, issn 0167-6997, 10 p.Article

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancerGOLDBERG, Richard M; SARGENT, Daniel J; MORTON, Roscoe F et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 23-30, issn 0732-183X, 8 p.Article

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer : N9741SANOFF, Hanna K; SARGENT, Daniel J; CAMPBELL, Megan E et al.Journal of clinical oncology. 2008, Vol 26, Num 35, pp 5721-5727, issn 0732-183X, 7 p.Article

Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer : A north American intergroup trialMEROPOL, Neal J; GOLDBERG, Richard M; SARGENT, Daniel J et al.Journal of clinical oncology. 2006, Vol 24, Num 21, issn 0732-183X, 3322-3324,3347-3353 [10 p.]Article

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer : Southwest oncology group trial S0003WILLIAMSON, Stephen K; CROWLEY, John J; LARA, Primo N et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9097-9104, issn 0732-183X, 8 p.Article

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : Intergroup trial n9741 in first-line treatment of metastatic colorectal cancerASHLEY, Amanda C; SARGENT, Daniel J; PITOT, Henry C et al.Cancer. 2007, Vol 110, Num 3, pp 670-677, issn 0008-543X, 8 p.Article

Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer : GI INT 0144SMALLEY, Stephen R; BENEDETTI, Jacqueline K; BENSON, Al B et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3542-3547, issn 0732-183X, 6 p.Article

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer : Results from intergroup N9741DY, Grace K; KROOK, James E; POCKAJ, Barbara A et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3469-3474, issn 0732-183X, 6 p.Article